226 papers found
Refreshing results…
Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patient
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer
Persistence of survivin specific T cells for seven years in a melanoma patient During domplete remission
Reactivity of naive CD4+CD25- T cells against gut microflora in healthy mice
Longitudinal Studies of Clonally Expanded CD8 T Cells Reveal a Repertoire Shrinkage Predicting Mortality and an Increased Number of Dysfunctional Cytomegalovirus-Specific T Cells in the Very Elderly
Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells
Cytotoxic T Cells
Cancer Cells Become Susceptible to Natural Killer Cell Killing after Exposure to Histone Deacetylase Inhibitors Due to Glycogen Synthase Kinase-3–Dependent Expression of MHC Class I–Related Chain A and B
Evidence for Involvement of Clonally Expanded CD8+ T Cells in Anti-Cancer Immune Responses in CLL Patients Following Nonmyeloablative Conditioning and Hematopoietic Cell Transplantation (HCT).
Spontaneous Immunity against Bcl-xL in Cancer Patients
Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes
Regulators of apoptosis: suitable targets for immune therapy of cancer
The paradoxical association between Bcl-2 expression and prognosis: does the immune system make the difference?
Immunogenicity of Bcl-2 in patients with cancer
Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin
Towards discovery-driven translational research in breast cancer. FEBS J
Inhibitors of Apoptosis (IAP) as Targets for Spontaneous T-Cell Responses in Cancer Patients: Potential Universal Antigens in Therapeutic Vaccinations Against Cancer:
Characterization of mouse MAGE-derived H-2K b -restricted CTL epitopes
Spontaneous T-cell responses against peptides derived from the Taxol resistance–associated gene-3 (TRAG-3) protein in cancer patients
Immunogenicity of Constitutively Active V599EBRaf
Missing publications? Read more about our data sources.